Researchers track Real-World menopause treatment use after drug trials
NCT ID NCT06949553
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study looks at how women treated their menopause hot flashes before and after taking part in earlier clinical trials for the drug elizanetant. Researchers will survey participants and review their medical records to see which treatments they used, whether they stuck with them, and why. No new treatments are given—the goal is simply to learn more about real-world care patterns.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
24 people
The number who actually took part.
- Started
-
Apr 2025
- Finished
-
Aug 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Females from 40 to 65 years, naturally or surgically postmenopausal, who had experienced 50 or more moderate to severe VMS over 7 days during screening
- Ages
-
40 to 65 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients in the US who participated in one of the three OASIS trials for patients with moderate-to-severe VMS related to menopause. * Patients who confirmed interest in being contacted for further study communication * Patients who consent to be included in the registry, complete the pre-OASIS trial survey, and agree to be tokenized so that their anonymized real-world data can be accessed Exclusion Criteria: * None
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Vasomotor symptoms (VMS) associated with menopause are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bayer US
Whippany, New Jersey, 07981, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.